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113patient with PXE (2). In that report, the stenosis was
successfully treated by the conventional techniques. How-
ever, lesion pathology in PXE is reported to be different
from atherosclerosis (3).
A 26-year-old Japanese woman was diagnosed with PXE.
She had typical skin involvement (yellow cobblestone ap-
pearance of the neck and elastofibroma on skin histopathol-
ogy) and eye involvement (angioid streak). She was referred
to our cardiology division for examination of coronary artery
disease. The multidetector computed tomography (MDCT)
images revealed significant stenoses of the mid left anterior
descending coronary artery (LAD) and the left circumflex
coronary artery. However, no coronary calcification was
visible. Coronary angiography revealed severe stenoses with-
out visible calcification, consistent with the findings on
MDCT (Fig. 1A).
Transfemoral PCI was tried to treat the LAD stenosis.
Intravascular ultrasound (IVUS) (View It, Terumo, Tokyo)
revealed a superficial high echoic component around vessels
without acoustic shadowing (Fig. 1B). A 3.0  18-mm
bare-metal stent (Driver, Medtronic, Minneapolis, Minne-
sota) was deployed (maximum inflation pressure of 16 atm).
Post-dilations using several noncompliant balloons, such as
the 3.75-mm Quantum Maverick (Boston Scientific Cor-
poration, Natick, Massachusetts), were performed (maxi-
mum inflation pressure of 24 atm) (Fig. 1C). Unfortunately,
the final angiogram showed stent underexpansion (Fig. 1D).
Minimum stent area of the lesion was 4.4 cm2 (Fig. 1E).
We added bisoprolol for the treatment of other nondilated
vessels.Intimal calcification in the coronary artery is 1 of the
characteristics of atherosclerosis. By contrast, intimal fibro-
sis in the coronary artery is an idiopathic change with PXE
(3,4). Although there was no visible calcification on both
MDCT and angiography, IVUS suggested the presence of
dense intimal fibrosis. This dense fibrosis might impede the
stent expansion. Our case suggests the necessity of taking a
cautious approach in PCI of lesions in patients with PXE,
because the presence of dense fibrosis, which is invisible by
angiogram or MDCT, may inhibit the vessel expansion.
Cautious and aggressive pre-dilation before stenting may be
needed to prevent stent underexpansion.
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